These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38991582)

  • 1. Self-guided digital behavioural therapy versus active control for fibromyalgia (PROSPER-FM): a phase 3, multicentre, randomised controlled trial.
    Gendreau RM; McCracken LM; Williams DA; Luciano JV; Dai Y; Vega N; Ghalib Z; Guthrie K; Kraus AC; Rosenbluth MJ; Vaughn B; Zomnir JM; Reddy D; Chadwick AL; Clauw DJ; Arnold LM
    Lancet; 2024 Jul; 404(10450):364-374. PubMed ID: 38991582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-guided digital acceptance and commitment therapy for fibromyalgia management: results of a randomized, active-controlled, phase II pilot clinical trial.
    Catella S; Gendreau RM; Kraus AC; Vega N; Rosenbluth MJ; Soefje S; Malhotra S; Luciano JV; McCracken LM; Williams DA; Arnold LM
    J Behav Med; 2024 Feb; 47(1):27-42. PubMed ID: 37382794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Person-centred experiential therapy versus cognitive behavioural therapy delivered in the English Improving Access to Psychological Therapies service for the treatment of moderate or severe depression (PRaCTICED): a pragmatic, randomised, non-inferiority trial.
    Barkham M; Saxon D; Hardy GE; Bradburn M; Galloway D; Wickramasekera N; Keetharuth AD; Bower P; King M; Elliott R; Gabriel L; Kellett S; Shaw S; Wilkinson T; Connell J; Harrison P; Ardern K; Bishop-Edwards L; Ashley K; Ohlsen S; Pilling S; Waller G; Brazier JE
    Lancet Psychiatry; 2021 Jun; 8(6):487-499. PubMed ID: 34000240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of digital measurement of medication adherence and lung function to guide the management of uncontrolled asthma (INCA Sun): a multicentre, single-blinded, randomised clinical trial.
    Hale EM; Greene G; Mulvey C; Mokoka MC; van Boven JFM; Cushen B; Sulaiman I; Brennan V; Lombard L; Walsh J; Plunkett S; McCartan TA; Kerr PJ; Reilly RB; Hughes C; Kent BD; Jackson DJ; Butler M; Counihan I; Hayes J; Faul J; Kelly M; Convery R; Nanzer AM; Fitzgerald JM; Murphy DM; Heaney LG; Costello RW;
    Lancet Respir Med; 2023 Jul; 11(7):591-601. PubMed ID: 36963417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive behavioural therapy for adults with dissociative seizures (CODES): a pragmatic, multicentre, randomised controlled trial.
    Goldstein LH; Robinson EJ; Mellers JDC; Stone J; Carson A; Reuber M; Medford N; McCrone P; Murray J; Richardson MP; Pilecka I; Eastwood C; Moore M; Mosweu I; Perdue I; Landau S; Chalder T;
    Lancet Psychiatry; 2020 Jun; 7(6):491-505. PubMed ID: 32445688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized Controlled Trial of Online Acceptance and Commitment Therapy for Fibromyalgia.
    Simister HD; Tkachuk GA; Shay BL; Vincent N; Pear JJ; Skrabek RQ
    J Pain; 2018 Jul; 19(7):741-753. PubMed ID: 29481976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of continuous subcutaneous levodopa-carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial.
    Espay AJ; Stocchi F; Pahwa R; Albanese A; Ellenbogen A; Ferreira JJ; Giladi N; Gurevich T; Hassin-Baer S; Hernandez-Vara J; Isaacson SH; Kieburtz K; LeWitt PA; Lopez-Manzanares L; Olanow CW; Poewe W; Sarva H; Yardeni T; Adar L; Salin L; Lopes N; Sasson N; Case R; Rascol O;
    Lancet Neurol; 2024 May; 23(5):465-476. PubMed ID: 38499015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Online remote behavioural intervention for tics in 9- to 17-year-olds: the ORBIT RCT with embedded process and economic evaluation.
    Hollis C; Hall CL; Khan K; Le Novere M; Marston L; Jones R; Hunter R; Brown BJ; Sanderson C; Andrén P; Bennett SD; Chamberlain LR; Davies EB; Evans A; Kouzoupi N; McKenzie C; Heyman I; Kilgariff J; Glazebrook C; Mataix-Cols D; Serlachius E; Murray E; Murphy T
    Health Technol Assess; 2023 Oct; 27(18):1-120. PubMed ID: 37924247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study protocol for a three-arm randomized controlled trial investigating the effectiveness, cost-utility, and physiological effects of a fully self-guided digital Acceptance and Commitment Therapy for Spanish patients with fibromyalgia.
    Gallego A; Serrat M; Royuela-Colomer E; Sanabria-Mazo JP; Borràs X; Esteve M; Grasa M; Rosa A; Rozadilla-Sacanell A; Almirall M; D'Amico F; Dai Y; Rosenbluth MJ; McCracken LM; Navarrete J; Feliu-Soler A; Luciano JV
    Digit Health; 2024; 10():20552076241239177. PubMed ID: 38550263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipsychotic medication versus psychological intervention versus a combination of both in adolescents with first-episode psychosis (MAPS): a multicentre, three-arm, randomised controlled pilot and feasibility study.
    Morrison AP; Pyle M; Maughan D; Johns L; Freeman D; Broome MR; Husain N; Fowler D; Hudson J; MacLennan G; Norrie J; Shiers D; Hollis C; James A;
    Lancet Psychiatry; 2020 Sep; 7(9):788-800. PubMed ID: 32649925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the effect of a digital health intervention to enhance physical activity in people with chronic kidney disease (Kidney BEAM): a multicentre, randomised controlled trial in the UK.
    Greenwood SA; Young HML; Briggs J; Castle EM; Walklin C; Haggis L; Balkin C; Asgari E; Bhandari S; Burton JO; Billany RE; Bishop NC; Bramham K; Campbell J; Chilcot J; Cooper NJ; Deelchand V; Graham-Brown MPM; Hamilton A; Jesky M; Kalra PA; Koufaki P; McCafferty K; Nixon AC; Noble H; Saynor Z; Taal MW; Tollit J; Wheeler DC; Wilkinson TJ; Worboys H; Macdonald JH
    Lancet Digit Health; 2024 Jan; 6(1):e23-e32. PubMed ID: 37968170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acceptance and Commitment Therapy plus usual care for improving quality of life in people with motor neuron disease (COMMEND): a multicentre, parallel, randomised controlled trial in the UK.
    Gould RL; McDermott CJ; Thompson BJ; Rawlinson CV; Bursnall M; Bradburn M; Kumar P; Turton EJ; White DA; Serfaty MA; Graham CD; McCracken LM; Goldstein LH; Al-Chalabi A; Orrell RW; Williams T; Noad R; Baker I; Faull C; Lambert T; Chhetri SK; Ealing J; Hanratty A; Radunovic A; Gunawardana N; Meadows G; Gorrie GH; Young T; Lawrence V; Cooper C; Shaw PJ; Howard RJ;
    Lancet; 2024 Jun; 403(10442):2381-2394. PubMed ID: 38735299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapist-supported online remote behavioural intervention for tics in children and adolescents in England (ORBIT): a multicentre, parallel group, single-blind, randomised controlled trial.
    Hollis C; Hall CL; Jones R; Marston L; Novere ML; Hunter R; Brown BJ; Sanderson C; Andrén P; Bennett SD; Chamberlain LR; Davies EB; Evans A; Kouzoupi N; McKenzie C; Heyman I; Khan K; Kilgariff J; Glazebrook C; Mataix-Cols D; Murphy T; Serlachius E; Murray E
    Lancet Psychiatry; 2021 Oct; 8(10):871-882. PubMed ID: 34480868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of group acceptance and commitment therapy for fibromyalgia: a 6-month randomized controlled trial (EFFIGACT study).
    Luciano JV; Guallar JA; Aguado J; López-Del-Hoyo Y; Olivan B; Magallón R; Alda M; Serrano-Blanco A; Gili M; Garcia-Campayo J
    Pain; 2014 Apr; 155(4):693-702. PubMed ID: 24378880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subthalamic nucleus deep brain stimulation with a multiple independent constant current-controlled device in Parkinson's disease (INTREPID): a multicentre, double-blind, randomised, sham-controlled study.
    Vitek JL; Jain R; Chen L; Tröster AI; Schrock LE; House PA; Giroux ML; Hebb AO; Farris SM; Whiting DM; Leichliter TA; Ostrem JL; San Luciano M; Galifianakis N; Verhagen Metman L; Sani S; Karl JA; Siddiqui MS; Tatter SB; Ul Haq I; Machado AG; Gostkowski M; Tagliati M; Mamelak AN; Okun MS; Foote KD; Moguel-Cobos G; Ponce FA; Pahwa R; Nazzaro JM; Buetefisch CM; Gross RE; Luca CC; Jagid JR; Revuelta GJ; Takacs I; Pourfar MH; Mogilner AY; Duker AP; Mandybur GT; Rosenow JM; Cooper SE; Park MC; Khandhar SM; Sedrak M; Phibbs FT; Pilitsis JG; Uitti RJ; Starr PA
    Lancet Neurol; 2020 Jun; 19(6):491-501. PubMed ID: 32470421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurofeedback, sham neurofeedback, and cognitive-behavioural group therapy in adults with attention-deficit hyperactivity disorder: a triple-blind, randomised, controlled trial.
    Schönenberg M; Wiedemann E; Schneidt A; Scheeff J; Logemann A; Keune PM; Hautzinger M
    Lancet Psychiatry; 2017 Sep; 4(9):673-684. PubMed ID: 28803030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes and cost-effectiveness of brief guided parent-delivered cognitive behavioural therapy and solution-focused brief therapy for treatment of childhood anxiety disorders: a randomised controlled trial.
    Creswell C; Violato M; Fairbanks H; White E; Parkinson M; Abitabile G; Leidi A; Cooper PJ
    Lancet Psychiatry; 2017 Jul; 4(7):529-539. PubMed ID: 28527657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapist telephone-delivered CBT and web-based CBT compared with treatment as usual in refractory irritable bowel syndrome: the ACTIB three-arm RCT.
    Everitt H; Landau S; Little P; Bishop FL; O'Reilly G; Sibelli A; Holland R; Hughes S; Windgassen S; McCrone P; Goldsmith K; Coleman N; Logan R; Chalder T; Moss-Morris R
    Health Technol Assess; 2019 Apr; 23(17):1-154. PubMed ID: 31042143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of tralokinumab in patients with severe uncontrolled asthma: a randomised, double-blind, placebo-controlled, phase 2b trial.
    Brightling CE; Chanez P; Leigh R; O'Byrne PM; Korn S; She D; May RD; Streicher K; Ranade K; Piper E
    Lancet Respir Med; 2015 Sep; 3(9):692-701. PubMed ID: 26231288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.